Rex H Lee

11PUBLICATIONS
12CO-AUTHORS
Predictive and prognostic markersMolecular targetsOral and maxillofacial surgeryCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumours
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 18, 2026
Metastatic Lymph Node Status Is Associated With Progression-Free Survival in Oral Cavity Squamous Cell Carcinoma Treated With Pembrolizumab.

|May 10, 2026
Neutrophil-To-Lymphocyte Ratio and Survival in Pembrolizumab-Treated Oropharyngeal Cancer.

|Jan 03, 2026
Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma.

Angeline A Truong, Savinnie Ho, Rex H Lee

|Jan 09, 2025
HPV-associated Sinonasal Squamous Cell Carcinoma.

Rex H Lee, Annemieke van Zante, Ezequiel Goldschmidt

|Oct 28, 2023
The neutrophil-to-lymphocyte ratio in salivary gland cancers treated with pembrolizumab.

Rex H Lee, Angeline Truong, Xin Wu

|Oct 02, 2023
To Tip or Not to Tip: A New Combination for Precision Medicine in Head and Neck Cancer.

Rex H Lee, Daniel E Johnson, Jennifer R Grandis

Pageof 2

Frequent Collaborators

5 joint publications

Hyunseok Kang

4 joint publications

Ivan H El-Sayed

4 joint publications

Katherine C Wai

3 joint publications

Angeline A Truong